Foresight Wealth Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,099
Closed -$224K 128
2022
Q1
$224K Buy
3,099
+462
+18% +$33.3K 0.04% 92
2021
Q4
$242K Sell
2,637
-50
-2% -$5.98K ﹤0.01% 109
2021
Q3
$341K Buy
2,687
+250
+10% +$36.4K 0.07% 90
2021
Q2
$405K Buy
2,437
+286
+13% +$46.3K 0.09% 82
2021
Q1
$391K Buy
+2,151
New +$499K 0.1% 85

Other funds holding TDOC

Foresight Wealth Management's TDOC Position: Q2 2022 in Review

Foresight Wealth Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 3,099 shares — an estimated $224K sold.

Foresight Wealth Management first reported a position in TDOC in Q1 2021 and held it in 5 quarters. The position peaked at $405K in Q2 2021. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Foresight Wealth Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Foresight Wealth Management sold 3,099 Teladoc Health shares in Q2 2022, an estimated $224K.
  • Foresight Wealth Management first reported a position in Teladoc Health in Q1 2021 and held it in 5 quarters.
  • Foresight Wealth Management's Teladoc Health position peaked at $405K in Q2 2021.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Foresight Wealth Management's 13F filing for Q2 2022, filed 29 Jul 2022.